Skip to main content

Table 1 Effects of CIS and/or RSVL treatment on the therapeutic action of CIS in mice bearing Ehrlich ascites carcinoma cells

From: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals

Treatment Mean survival time(days) 45-day survivors
Control 17 ± 3.74 0/10
RSVL (25 mg/kg) 12 ± 5.95b 0/10
CIS (5 mg/kg) 25 ± 12.13 2/10
CIS (5 mg/kg) + RSVL (25 mg/kg) (supplied simultaneously) 48 ± 15.03a,b 6/10
  1. Each data represents the mean ± S.D. of ten mice.
  2. aSignificantly different from control at P-value < 0.05. bSignificantly different from CIS at P-value < 0.05.